Detalhe da pesquisa
1.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
J Neurol Neurosurg Psychiatry
; 95(5): 392-400, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963723
2.
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
Ann Hematol
; 96(4): 653-663, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28116479
3.
Modifying the Medical Research Council grading system through Rasch analyses.
Brain
; 135(Pt 5): 1639-49, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189568
4.
Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.
J Neurol Sci
; 260(1-2): 124-31, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17543994
5.
Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy.
J Neuroimmunol
; 175(1-2): 152-9, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600385
6.
Painful ophthalmoplegia from metastatic nonproducing parathyroid carcinoma: case study and review of the literature.
Neuro Oncol
; 4(1): 44-8, 2002 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11772432
7.
[Concentration problem or epilepsy? Sudden changes in behaviour in adolescents]. / Concentratiestoornis of epilepsie? Adolescenten met plotselinge gedragsveranderingen.
Ned Tijdschr Geneeskd
; 158: A8030, 2014.
Artigo
em Holandês
| MEDLINE | ID: mdl-25387982
8.
Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.
J Neuroimmunol
; 268(1-2): 89-94, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529728